Deep Track Capital, LP - 31 Dec 2025 SCHEDULE 13G/A Report for Viridian Therapeutics, Inc. Common Stock, $0.01 par value per share (VRDN)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
Viridian Therapeutics, Inc. Common Stock, $0.01 par value per share
Symbol
VRDN
Shares outstanding
95,276,717 shares
Disclosed Ownership
2,524,833 shares
Ownership
2.6%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2026, 08:53:06 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Deep Track Capital, LP disclosed 2.6% ownership in Viridian Therapeutics, Inc. Common Stock, $0.01 par value per share (VRDN) on 31 Dec 2025."

Quick Takeaways

  • Deep Track Capital, LP filed SCHEDULE 13G/A for Viridian Therapeutics, Inc. Common Stock, $0.01 par value per share (VRDN).
  • Disclosed ownership: 2.6%.
  • Date of event: 31 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 13 Feb 2026, 08:53.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 2.6% 2,524,833 0 2,524,833 /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 2.6% 2,524,833 0 2,524,833 /s/ David Kroin David Kroin, Director
David Kroin 2.6% 2,524,833 0 2,524,833 /s/ David Kroin David Kroin

Sponsored